• Journal
  • General Interest
  • Pulmonary
In study after study, marijuana use has been found to be associated with increased forced vital capacity (FVC).
0
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Participation
  • Journal
  • General Interest
  • Pulmonary
Chronic obstructive pulmonary disease (COPD) is a major public health problem in the Americas (a region of the world comprising North, Central, and South America), although there is substantial var
0
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Participation
  • Journal
  • General Interest
  • Pulmonary
Alpha-1 antitrypsin deficiency (AATD) is an underrecognized condition with only a small minority of affected individuals diagnosed, long delays between initial symptoms and diagnosis, and evidence
0
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Participation
  • Journal
  • General Interest
  • Pulmonary
An evidence-based guideline for the treatment of patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD) was created in 2023 by a panel of multidisciplinary experts. 
0
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Participation
  • Journal
  • General Interest
  • Pulmonary
Hematopoietic stem cell transplant (HSCT) is an established treatment for many pediatric malignant and nonmalignant conditions with increasing rates each year worldwide.
0
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Participation

Pages